US Commerce Dept Exempts Specialty, Rare-Disease Drugs From India From New Tariffs – PGurus
US Commerce Dept Exempts Specialty, Rare-Disease Drugs From India From New Tariffs PGurus Read the full…
US Commerce Dept Exempts Specialty, Rare-Disease Drugs From India From New Tariffs PGurus Read the full…
Pharma stocks rise up to 5% as US exempts select specialty drugs from 100% tariff;…
US waives 100 pc tariff on select Indian speciality drugs: What it means for pharma…
US 100% pharma tariff: Amid uncertainty, India gets exemption for select specialty drugs and ingredients Livemint…
India opens anti-dumping probes into seven Chinese products across pharma, rubber, elevators The Tribune Read the…
Sanofi Healthcare buys 15.2% stake in Sanofi India for Rs 1,068 crore ETPharma.com Read the full…
India Among Countries Getting Zero US Tariffs on Select Specialty Pharma Products Medical Dialogues Read the…
Ind-Ra pegs Pharma FY27 revenue growth at 10% as domestic demand, CDMOs cushion US decline ETPharma.com…
US Exempts Select Indian Specialty Drugs From Tariff IndiaWest Read the full story at source →
India among 20 jurisdictions exempted from US tariff on speciality drugs firstpost.com Read the full story…